Israel reports 93 new measles cases, total at 410
The ministry on Sunday estimated that, due to the high hospitalisation rate and community reports, the number of infected people in the current outbreak in Israel ranges from 950 to 1,700.
According to the ministry, the number of active diagnosed patients has increased from 120 to 162, including 22 currently hospitalised.
Two of the hospitalised patients, a one-year-old baby and a toddler nearly two and a half years old, are currently receiving ECMO support in the intensive care unit.
About a month after the outbreak, the ministry launched a nationwide vaccination completion campaign, and since then, more than 105,000 doses have been administered.
Measles is an extremely contagious viral illness characterised by common symptoms, including fever, fatigue, runny nose, and a distinctive rash. In some cases, it can result in severe or potentially life-threatening complications.
The ministry also reported a new case of West Nile fever in the southern city of Beer Sheva. This is the second confirmed case of the disease in Israel, following a diagnosis in central Israel in early June, Xinhua news agency reported.
Measles infects the respiratory tract and then spreads throughout the body. Symptoms include a high fever, cough, runny nose and a rash all over the body.
Being vaccinated is the best way to prevent getting sick with measles or spreading it to other people. The vaccine is safe and helps your body fight off the virus.
Before the introduction of the measles vaccine in 1963 and widespread vaccination, major epidemics occurred approximately every two to three years and caused an estimated 2.6 million deaths each year.
An estimated 107,500 people died from measles in 2023 -- mostly children under the age of five years, despite the availability of a safe and cost-effective vaccine.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hans India
15 hours ago
- Hans India
Israel reports 93 new measles cases, total at 410
Jerusalem: The Israeli Health Ministry reported 93 new diagnosed cases of measles, bringing the total in the current outbreak, which began in early April, to 410. The ministry on Sunday estimated that, due to the high hospitalisation rate and community reports, the number of infected people in the current outbreak in Israel ranges from 950 to 1,700. According to the ministry, the number of active diagnosed patients has increased from 120 to 162, including 22 currently hospitalised. Two of the hospitalised patients, a one-year-old baby and a toddler nearly two and a half years old, are currently receiving ECMO support in the intensive care unit. About a month after the outbreak, the ministry launched a nationwide vaccination completion campaign, and since then, more than 105,000 doses have been administered. Measles is an extremely contagious viral illness characterised by common symptoms, including fever, fatigue, runny nose, and a distinctive rash. In some cases, it can result in severe or potentially life-threatening complications. The ministry also reported a new case of West Nile fever in the southern city of Beer Sheva. This is the second confirmed case of the disease in Israel, following a diagnosis in central Israel in early June, Xinhua news agency reported. Measles infects the respiratory tract and then spreads throughout the body. Symptoms include a high fever, cough, runny nose and a rash all over the body. Being vaccinated is the best way to prevent getting sick with measles or spreading it to other people. The vaccine is safe and helps your body fight off the virus. Before the introduction of the measles vaccine in 1963 and widespread vaccination, major epidemics occurred approximately every two to three years and caused an estimated 2.6 million deaths each year. An estimated 107,500 people died from measles in 2023 -- mostly children under the age of five years, despite the availability of a safe and cost-effective vaccine.
Hans India
3 days ago
- Hans India
Mpox deaths surpass 1,900 in Africa since 2024: Africa CDC
Addis Ababa: The death toll from Africa's ongoing mpox outbreak has surpassed 1,900 since the start of 2024, the Africa Centres for Disease Control and Prevention (Africa CDC) said. During an online media briefing, Ngashi Ngongo, chief of staff and head of the Africa CDC's Executive Office, said that 27 mpox-affected African countries have reported 174,597 cases and 1,922 related deaths since the start of last year. "When we compare the data of last year and this year, we see that in 2025, we have already reported 94,300 cases that represent 117 per cent of the cases reported last year. On the confirmed cases, we have 29,084 (this year) compared to 19,713 (last year)," Ngongo said. He noted, however, that the continent has seen a steady decline in both confirmed and suspected cases in recent weeks, especially compared to the peak in May. Increased testing coverage was also highlighted as a positive sign in the fight against the disease, Xinhua news agency reported. Mpox, formerly known as monkeypox, was first detected in laboratory monkeys in 1958. It is a rare viral disease typically transmitted through body fluids, respiratory droplets, and contaminated materials. The infection often causes fever, rash, and swollen lymph nodes. The Africa CDC declared the outbreak a public health emergency of continental security in August 2024. The World Health Organization later designated it a public health emergency of international concern. Mpox spreads from person to person mainly through close contact with someone who has mpox, including members of a household. Close contact includes skin-to-skin and mouth-to-mouth or mouth-to-skin contact, and it can also include being face-to-face with someone who has mpox (such as talking or breathing close to one another, which can generate infectious respiratory particles). Mpox causes signs and symptoms which usually begin within a week but can start 1–21 days after exposure. Symptoms typically last 2–4 weeks but may last longer in someone with a weakened immune system. Mpox causes signs and symptoms which usually begin within a week but can start 1–21 days after exposure. Symptoms typically last 2–4 weeks but may last longer in someone with a weakened immune system.
Hans India
3 days ago
- Hans India
WHO declares Kenya free of sleeping sickness
Nairobi: The World Health Organisation (WHO) certified Kenya as having eliminated human African trypanosomiasis, also known as sleeping sickness, as a public health challenge, making it the 10th country to reach this critical milestone. "I congratulate the government and people of Kenya on this landmark achievement," said WHO Director-General Tedros Adhanom Ghebreyesus in a statement issued in Nairobi, the Kenyan capital. "Kenya joins the growing ranks of countries freeing their populations of human African trypanosomiasis. This is another step toward making Africa free of neglected tropical diseases," Tedros added. Human African trypanosomiasis is the second neglected tropical disease to be eliminated in Kenya, following the country's certification as Guinea worm disease-free in 2018. The disease is caused by protozoan parasites transmitted by infected tsetse flies, according to the WHO. Symptoms include fever, headaches, joint pain, and, in advanced stages, neurological symptoms like confusion, disrupted sleep patterns, and behavioral changes. Aden Duale, Kenya's cabinet secretary for health, said the WHO validation of sleeping sickness elimination marked a historic step toward enhancing public health security in the country, fostering economic growth. Kenya detected the first case of sleeping sickness in the early 20th century and has since engaged in robust mitigation activities. The last two exported cases were detected in 2012 in the world-famous Maasai Mara National Reserve, Xinhua news agency reported. In recent years, the country has enhanced sleeping sickness surveillance in 12 health facilities across six historically endemic counties, which serve as sentinel sites. This effort is complemented by the use of modern diagnostic tools and the training of personnel to avert new transmission. Abdourahmane Diallo, the WHO representative in Kenya, said forward-looking leadership and partnerships were pivotal in accelerating progress toward sleeping sickness elimination in the East African country. Human African trypanosomiasis, also known as sleeping sickness, is a vector-borne parasitic disease. It is caused by protozoans of the genus Trypanosoma, transmitted to humans by bites of tsetse flies (glossina) which have acquired the parasites from infected humans or animals. Tsetse flies inhabit sub-Saharan Africa and only certain species transmit the disease. Rural populations which depend on agriculture, fishing, animal husbandry or hunting are the most exposed. In many regions where tsetse flies are found, HAT is not. The disease has a focal distribution ranging from single villages to entire regions, and the incidence can vary from one village to the next.
